[1]

WHO. Media centre. Cardiovascular diseases (CVDs)[DB/OL]. http://www.who.int/mediacentre/factsheets/fs317/en/.html.
[2] Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J, 2003, 24(11): 987-1003.  doi: 10.1016/S0195-668X(03)00114-3
[3] Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the Third Report of the National Cholesterol Education Program(NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel Ⅲ). JAMA, 2001, 285(19): 2486-2497.  doi: 10.1001/jama.285.19.2486
[4] Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA, 2003, 289(19): 2560-2572.  doi: 10.1001/jama.289.19.2560
[5] Greenland P, Smith SC, Jr, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation, 2001, 104(15): 1863-1867.  doi: 10.1161/hc4201.097189
[6] Lauer MS. Clinical practice. Aspirin for primary prevention of coronary events. N Engl J Med, 2002, 346(19): 1468-1474.  doi: 10.1056/NEJMcp012672
[7] Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk asssessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography)developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol, 2007, 49(3): 378-402.  doi: 10.1016/j.jacc.2006.10.001
[8] Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA, 1987, 257(16): 2176-2180.  doi: 10.1001/jama.1987.03390160062027
[9] Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med, 1997, 337(19): 1360-1369.  doi: 10.1056/NEJM199711063371906
[10] Mosca L, Edelman D, Mochari H, et al. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day. J Womens Health (Larchmt), 2006, 15(1): 24-34.  doi: 10.1089/jwh.2006.15.24
[11] Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the Amercian Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation, 2006, 114(16): 1761-1791.  doi: 10.1161/CIRCULATIONAHA.106.178458
[12] Beckman JA, Ganz J, Creager MA, et al. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol, 2001, 21(10): 1618-1622.  doi: 10.1161/hq0901.095554
[13] Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation, 1995, 92(8): 2157-2162.  doi: 10.1161/01.CIR.92.8.2157
[14] Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25, 253 patients. J Am Coll Cardiol, 2007, 49(18): 1860-1870.  doi: 10.1016/j.jacc.2006.10.079
[15] Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA, 2004, 291(2): 210-215.  doi: 10.1001/jama.291.2.210
[16] Nasir K, Budoff MJ, Post WS, et al. Electron beam CT versus helical CT scans for assessing coronary calcification: current utility and future directions. Am Heart J, 2003, 146(6): 969-977.  doi: 10.1016/S0002-8703(03)00450-2
[17] O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000, 36(1): 326-340.  doi: 10.1016/S0735-1097(00)00831-7
[18] Kennedy J, Shavelle R, Wang S, et al. Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J, 1998, 135(4): 696-702.  doi: 10.1016/S0002-8703(98)70288-1
[19] Khandaker MH, Miller TD, Chareonthaitawee P, et al. Stress single photon emission computed tomography for detection of coronary artery disease and risk stratification of asymptomatic patients at moderate risk. J Nucl Cardiol, 2009, 16(4): 516-523.  doi: 10.1007/s12350-009-9085-x
[20] Blumenthal RS, Becker DM, Yanek LR, et al. Comparison of coronary calcium and stress myocardial perfusion imaging in apparently healthy siblings of individuals with premature coronary artery disease. Am J Cardiol, 2006, 97(3): 328-333.  doi: 10.1016/j.amjcard.2005.08.048
[21] Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J, 2006, 27(6): 713-721.  doi: 10.1093/eurheartj/ehi808
[22] Schenker MP, Dorbala S, Hong EC, et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation, 2008, 117(13): 1693-1700.  doi: 10.1161/CIRCULATIONAHA.107.717512
[23] 朱玫, 潘中允, 林景辉, 等. 运动试验心肌显像异常及其类型对冠心病患者预后判断的价值. 中华核医学杂志, 1998, 18(2): 95-96.
[24] Schenker MP, Dorbala S, Hong EC, et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation, 2008, 117(13): 1693-1700.  doi: 10.1161/CIRCULATIONAHA.107.717512
[25] Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardial, 2007, 49(2): 227-237.  doi: 10.1016/j.jacc.2006.08.048
[26] Chang SM, Nabi F, Xu J, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coil Cardiol, 2009, 54 (20): 1872-1882.  doi: 10.1016/j.jacc.2009.05.071
[27] Schepis T, Gaemperli O, Koepfli P, et al. Added value of coronary artery calcium score as an adjunct to gated SPECT for the evaluation of coronary artery disease in an intermediate-risk population. J Nucl Med, 2007, 48(9): 1424-1430.  doi: 10.2967/jnumed.107.040758
[28] Berman DS, Wong ND, Gransar H, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol, 2004, 44(4): 923-930.  doi: 10.1016/j.jacc.2004.06.042
[29] Haberl R, Becker A, Leber A, et al. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1, 764 patients. J Am Coll Cardiol, 2001, 37(2): 451-457.  doi: 10.1016/S0735-1097(00)01119-0
[30] Rosman J, Shapiro M, Pandey A, et al. Lack of correlation between coronary artery calcium and myocardial perfusion imaging. J Nucl Cardiol, 2006, 13(3): 333-337.  doi: 10.1016/j.nuclcard.2006.01.023